Neumora Therapeutics (NMRA) Long-Term Investments (2022 - 2024)
Neumora Therapeutics (NMRA) posted quarterly Long-Term Investments of $302000.0 for Q1 2024, down 96.93% quarter-over-quarter from $9.8 million in Q4 2023.
Neumora Therapeutics (NMRA) Long-Term Investments (2022 - 2024) Analysis & Trends
Neumora Therapeutics' Long-Term Investments history runs 3 years deep, the most recent figure standing at $302000.0 for Q1 2024.
- In Q1 2024, Long-Term Investments changed N/A year-over-year to $302000.0; the TTM figure through Mar 2024 stood at $302000.0 (changed N/A YoY), while the FY2023 annual figure was $9.8 million, down 58.13% from the prior year.
- Long-Term Investments for Q1 2024 stood at $302000.0, down from $9.8 million in the prior quarter.
- The five-year high for Long-Term Investments was $23.5 million in Q4 2022, with the low at $302000.0 in Q1 2024.
- The 3-year median for Long-Term Investments is $9.9 million (2023), against an average of $10.9 million.
- Peak annual rise in Long-Term Investments reached 58.13% in 2023, while the deepest fall reached 58.13% in 2023.
- Neumora Therapeutics' Long-Term Investments stood at $23.5 million in 2022, then sank by 58.13% to $9.8 million in 2023, then plunged by 96.93% to $302000.0 in 2024.
- Business Quant data shows NMRA's Long-Term Investments at $302000.0 in Q1 2024, $9.8 million in Q4 2023, and $9.9 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 372.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.17 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Neumora Therapeutics | 296.45 Mn | 296.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 302,000.00 |
| Dec 31, 2023 | 9.85 Mn |
| Sep 30, 2023 | 9.91 Mn |
| Dec 31, 2022 | 23.51 Mn |